Merck KGaA (FRA:MRK) has been assigned a €96.00 ($103.23) target price by analysts at JPMorgan Chase & Co. in a note issued to investors on Friday. The brokerage currently has a a “neutral” rating on the stock.

Several other research firms also recently weighed in on MRK. Citigroup Inc. set a €115.00 ($123.66) price objective on Merck KGaA and gave the company a “buy” rating in a report on Thursday, September 29th. BNP Paribas set a €114.00 ($122.58) price objective on Merck KGaA and gave the company a “buy” rating in a report on Friday, September 30th. Commerzbank AG set a €101.00 ($108.60) price objective on Merck KGaA and gave the company a “buy” rating in a report on Tuesday, August 30th. Bank of America Corp. set a €115.00 ($123.66) price objective on Merck KGaA and gave the company a “buy” rating in a report on Thursday, September 8th. Finally, Goldman Sachs Group Inc. set a €99.00 ($106.45) price objective on Merck KGaA and gave the company a “neutral” rating in a report on Monday, October 17th. One research analyst has rated the stock with a sell rating, twelve have issued a hold rating and ten have issued a buy rating to the stock. Merck KGaA presently has an average rating of “Hold” and an average price target of €101.50 ($109.14).

Analyst Recommendations for Merck KGaA (FRA:MRK)

Shares of Merck KGaA (FRA:MRK) opened at 96.19 on Friday. Merck KGaA has a one year low of €70.87 and a one year high of €100.00. The stock’s 50 day moving average is €95.68 and its 200-day moving average is €92.81. The stock has a market cap of €41.82 billion and a P/E ratio of 30.10.

Merck KGaA Company Profile

.

Receive News & Stock Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related stocks with our FREE daily email newsletter.